Spero Therapeutics

About:

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Website: http://sperotherapeutics.com/

Twitter/X: Spero_Tx

Top Investors: Pfizer, National Science Foundation, RA Capital Management, MRL Ventures Fund, Google Ventures

Description:

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.